DEVELOPMENT CENTER OF BIOTECHNOLGY;TAIVEX THERAPEUTICS CORPORATION
发明人:
Jiann-Jyh HUANG,Shih-Hsien CHUANG,Ying-Shuan Eda LEE,Yu-Ling HUANG,Johnson LAU
申请号：
US14645292
公开号：
US20150250794A1
申请日:
2015.03.11
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
